Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients

被引：0
|
作者：
I Zlobec
F Molinari
M Kovac
M P Bihl
H J Altermatt
J Diebold
H Frick
M Germer
M Horcic
M Montani
G Singer
H Yurtsever
A Zettl
L Terracciano
L Mazzucchelli
P Saletti
M Frattini
K Heinimann
A Lugli
机构：
[1] Institute for Pathology,Department of Biomedicine
[2] University Hospital of Basel,Department of Pathology
[3] Institute of Pathology,undefined
[4] Research Group Human Genetics,undefined
[5] University of Basel,undefined
[6] Pathologie Länggasse,undefined
[7] Institute for Pathology,undefined
[8] Cantonal Hospital of Lucerne,undefined
[9] Institute for Pathology,undefined
[10] Cantonal Hospital of Chur,undefined
[11] Institute for Pathology,undefined
[12] Cantonal Hospital of Winterthur,undefined
[13] Institute for Histological and Cytological Diagnostics,undefined
[14] University Hospital Zurich,undefined
[15] Institute for Pathology,undefined
[16] Cantonal Hospital of Baden,undefined
[17] Institute for Pathology,undefined
[18] Cantonal Hospital of Aarau,undefined
[19] Institute of Clinical Pathology,undefined
[20] Oncology Institute of Southern Switzerland,undefined
[21] Ospedale San Giovanni,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
colorectal cancer; TOPK; anti-EGFR therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 161
页数：10
相关论文
共 50 条
  • [1] Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
    Zlobec, I.
    Molinari, F.
    Kovac, M.
    Bihl, M. P.
    Altermatt, H. J.
    Diebold, J.
    Frick, H.
    Germer, M.
    Horcic, M.
    Montani, M.
    Singer, G.
    Yurtsever, H.
    Zettl, A.
    Terracciano, L.
    Mazzucchelli, L.
    Saletti, P.
    Frattini, M.
    Heinimann, K.
    Lugli, A.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 151 - 161
  • [2] PROGNOSTIC VALUE OF BRAF AND KRAS MUTATIONS IN COLORECTAL CANCER PATIENTS
    Murata, E. P.
    Stradella, A.
    Paez, D.
    Tobena Puyal, M.
    Sebio Garcia, A.
    Gonzalez, A.
    Targarona, E.
    Baiget, M.
    Barnadas, A.
    Martin-Richard, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 216 - 216
  • [3] Prognostic value of BRAF and KRAS mutations in colorectal cancer patients
    Murata, Paola
    Stradella, Agostina
    Paez, David
    Tobena, Maria
    Sebio, Ana
    Pare, Laia
    Gonzalez, Alan
    Espinosa, Inigo
    Targarona, Eduardo
    Gich, Ignasi
    Barnadas, Agust
    Baiget, Montserrat
    Martin-Richard, Marta
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
    Ucar, Gokhan
    Ergun, Yakup
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Dirikoc, Merve
    Esen, Irfan
    Bal, Oznur
    Uncu, Dogan
    [J]. MEDICINE, 2020, 99 (39) : E22407
  • [5] Diffuse TOPK expression is an adverse prognostic factor in KRAS and BRAF mutated colorectal cancer
    Zlobec, I
    Bihli, M.
    Terracciano, L.
    Lugli, A.
    [J]. VIRCHOWS ARCHIV, 2009, 455 : 47 - 47
  • [6] Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
    Zlobec, Inti
    Kovac, Michal
    Erzberger, Priska
    Molinari, Francesca
    Bihl, Michel P.
    Rufle, Alexander
    Foerster, Anja
    Frattini, Milo
    Terracciano, Luigi
    Heinimann, Karl
    Lugli, Alessandro
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (11) : 2569 - 2575
  • [7] Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer
    Kadowaki, Shigenori
    Kakuta, Miho
    Takahashi, Shuhei
    Takahashi, Akemi
    Arai, Yoshiko
    Nishimura, Yoji
    Yatsuoka, Toshimasa
    Ooki, Akira
    Yamaguchi, Kensei
    Matsuo, Keitaro
    Muro, Kei
    Akagi, Kiwamu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (04) : 1275 - 1283
  • [8] Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer
    Shigenori Kadowaki
    Miho Kakuta
    Shuhei Takahashi
    Akemi Takahashi
    Yoshiko Arai
    Yoji Nishimura
    Toshimasa Yatsuoka
    Akira Ooki
    Kensei Yamaguchi
    Keitaro Matsuo
    Kei Muro
    Kiwamu Akagi
    [J]. World Journal of Gastroenterology, 2015, 21 (04) : 1275 - 1283
  • [9] KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?
    Selcukbiricik, F.
    Yildiz, O.
    Tural, D.
    Ozturk, M. A.
    Demir, G.
    Ozguroglu, M.
    Erdamar, S.
    Buyukunal, E.
    Mandel, N. M.
    Serdengecti, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S397 - S397
  • [10] Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
    Lavacchi, Daniele
    Fancelli, Sara
    Roviello, Giandomenico
    Castiglione, Francesca
    Caliman, Enrico
    Rossi, Gemma
    Venturini, Jacopo
    Pellegrini, Elisa
    Brugia, Marco
    Vannini, Agnese
    Bartoli, Caterina
    Cianchi, Fabio
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345